Shiqiong Xu

机构：Shanghai University, Sun Yat-sen University, Shanghai Jiao Tong University, Shanghai Stomatological Hospital, Shanghai Eye Disease Prevention & Treatment Center, Shanghai Ninth People's Hospital, The First Affiliated Hospital, Sun Yat-sen University, Shanghai Institute of Hematology · ORCID：0000-0003-3811-6482

发表论文 70 篇 · 总被引 2765 次 · h-index 28

代表论文

• Lactate and lactylation in cancer (2025 · Signal Transduction and Targeted Therapy · 被引 410)
• Copper ionophore elesclomol selectively targets GNAQ/11-mutant uveal melanoma (2022 · Oncogene · 被引 62)
• Progranulin/EphA2 axis: A novel oncogenic mechanism in bladder cancer (2020 · Matrix Biology · 被引 35)
• The blue light signal transduction module FaCRY1-FaCOP1-FaHY5 regulates anthocyanin accumulation in cultivated strawberry (2023 · Frontiers in Plant Science · 被引 32)
• Whole-exome sequencing for ocular adnexal sebaceous carcinoma suggests PCDH15 as a novel mutation associated with metastasis (2020 · Modern Pathology · 被引 30)
• American Joint Committee on Cancer Tumor Staging System Predicts the Outcome and Metastasis Pattern in Conjunctival Melanoma (2022 · Ophthalmology · 被引 29)